by Texas Heart Institute Physician-scientists at The Texas Heart Institute announced today the results of the largest cell therapy trial in patients with heart failure to date. The therapy benefited patients by reducing the risk of heart attack and stroke and improving the heart’s ejection fraction, especially in patients who have high levels of inflammation....
Illustration of the heart. A heart failure treatment using umbilical cord-derived stem cells may lead to notable improvements in heart muscle function and quality of life, according to a new study published in Circulation Research, an American Heart Association journal. “We are encouraged by our findings because they could pave the way to a non-invasive, promising...
